Patient Square Capital LP Eye Point Pharmaceuticals, Inc. Transaction History
Patient Square Capital LP
- $277 Billion
- Q2 2025
A detailed history of Patient Square Capital LP transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Patient Square Capital LP holds 1,352,837 shares of EYPT stock, worth $14.5 Million. This represents 4.59% of its overall portfolio holdings.
Number of Shares
1,352,837
Previous 1,481,977
8.71%
Holding current value
$14.5 Million
Previous $8.03 Billion
58.49%
% of portfolio
4.59%
Previous 3.32%
Shares
4 transactions
Others Institutions Holding EYPT
# of Institutions
159Shares Held
67.1MCall Options Held
214KPut Options Held
994K-
Cormorant Asset Management, LP Boston, MA8.33MShares$89.5 Million7.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$73.1 Million2.2% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.8MShares$73.1 Million0.11% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.6MShares$49.4 Million0.09% of portfolio
-
Franklin Resources Inc San Mateo, CA4.3MShares$46.2 Million0.01% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $366M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...